Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 160 participants.

Also called NCT04760717

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04760717
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04760717. Randomized; triple masking; primary purpose treatment. Start 2021-03-19 (actual); primary completion 2026-02-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
Acronym
REDUCE
Condition
Intracerebral Hemorrhage
Condition
Spironolactone
Intervention (Drug)
Spironolactone Pill
Lead sponsor
Yale University (class: other)
Collaborator
American Heart Association (class: other)

Record details

Record id
cardio:ct-nct04760717
Content hash
c6cbf274df7382a86827092da9d0decca59a8849bda123c4bc40b5c13e2a9d16